Forms for drug-resistant TB programmes

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. Geneva: World Health Organization; 2014.

Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis.

Show details

Contents

< Prev Next >

PART 4Forms for drug-resistant TB programmes

Form 04Laboratory register for culture, Xpert MTB/RIF and drug susceptibility testing (DST)

Download PDF (63K)

Form 05Six-monthly report on detection of TB cases with rifampicin resistance (RR-TB) and multidrug resistance (MDR-TB)

Download PDF (56K)

Form 06Six-monthly report on enrolment of TB cases with rifampicin resistance (RR-TB) and multidrug resistance (MDR-TB) on second-line TB treatment

Download PDF (56K)

Form 07Quarterly report on interim results of TB cases with rifampicin resistance (RR-TB) and multidrug resistance (MDR-TB) on second-line TB treatment

Download PDF (53K)

Form 08Annual report of final outcomes of TB cases with rifampicin resistance (RR-TB), multidrug resistance (MDR-TB) and extensive drug resistance (XDR-TB) on second-line TB treatment

Download PDF (55K)

All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob).

Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution–should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html).

Bookshelf ID: NBK247421

Contents

< Prev Next >

PubReader
Print View
Cite this Page
Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. Geneva: World Health Organization; 2014. PART 4, Forms for drug-resistant TB programmes.
PDF version of this title (2.2M)

Other titles in this collection

WHO Guidelines Approved by the Guidelines Review Committee

Recent Activity

Clear Turn Off Turn On

Forms for drug-resistant TB programmes - Companion Handbook to the WHO Guideline...
Forms for drug-resistant TB programmes - Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis
protein NPGR2 isoform X1 [Vitis vinifera]
protein NPGR2 isoform X1 [Vitis vinifera]
gi|731389800|ref|XP_010650120.1|
Protein
Mus musculus docking protein 5 (Dok5), mRNA
Mus musculus docking protein 5 (Dok5), mRNA
gi|31981354|ref|NM_029761.2|
Nucleotide
Intellectual developmental disorder with nasal speech, dysmorphic facies, and va...
Intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies
MedGen

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Bookshelf

Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis.

PART 4Forms for drug-resistant TB programmes

Form 01Second-line TB treatment card

Form 02Second-line TB treatment register

Form 03Request for examination of biological specimen for TB